NCT01755611View on ClinicalTrials.gov

Bioequivalence Minocycline Bioequivalence

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

June 17, 2011

Primary Completion Date

June 25, 2011

Study Completion Date

June 25, 2011

Conditions
Skin Infections (Acne)
Interventions
DRUG

Minocycline 100mg

Test product

DRUG

Minocycline 100mg

Reference product

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY